Does acotinib need to be combined with other drugs?

Cotinib is commonly used as monotherapy to treat B cell lymphoma, specifically chronic lymphocytic leukemia (CLL ). However, specific treatment options may vary depending on the patient's disease characteristics and the physician's judgment. In some cases, doctors may consider combining acotinib with other drugs, chemotherapy, or immunotherapy to achieve a more comprehensive treatment effect. The decision to use combination therapy often depends on the specific condition of the patient, such as stage of disease, genotype, other potential complications, etc. Doctors will take these factors into consideration to develop an individualized treatment plan in order to maximize treatment effectiveness and improve the patient's quality of life. Patients should fully communicate with their doctors about their treatment plan and possible combination treatment strategies.